ACM
TFFP

AIGH Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

AIGH Capital Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,482
Closed -$207K – 53
2023
Q4 		$207K Sell
29,482
-76,727
-72% -$596K 0.08% 37
2023
Q3 		$929K Buy
106,209
+43,988
+71% +$412K 0.44% 41
2023
Q2 		$731K Sell
62,221
-7,344
-11% -$106K 0.3% 42
2023
Q1 		$1.19M Hold
69,565
– – 0.44% 43
2022
Q4 		$1.83M Buy
+69,565
New +$3.3M 0.6% 34

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

AIGH Capital Management's TFFP Position: Q1 2024 in Review

AIGH Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2024, closing a stake of 29,482 shares — an estimated $207K sold.

AIGH Capital Management first reported a position in TFFP in Q4 2022 and held it in 5 quarters. The position peaked at $1.83M in Q4 2022. 19 funds tracked by Wall St. Rank hold TFFP as of Q1 2024.

  • AIGH Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • AIGH Capital Management sold 29,482 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $207K.
  • AIGH Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • AIGH Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.83M in Q4 2022.
  • 19 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on AIGH Capital Management's 13F filing for Q1 2024, filed 14 May 2024.